Synlab AG
XETRA:SYAB
Synlab AG
Cash from Operating Activities
Synlab AG
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Synlab AG
XETRA:SYAB
|
Cash from Operating Activities
€363.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Cash from Operating Activities
€2.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Cash from Operating Activities
€4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
Vita 34 AG
XETRA:V3V
|
Cash from Operating Activities
€3.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Cash from Operating Activities
HK$208.8m
|
CAGR 3-Years
39%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Synlab AG's Cash from Operating Activities?
Cash from Operating Activities
363.1m
EUR
Based on the financial report for Dec 31, 2023, Synlab AG's Cash from Operating Activities amounts to 363.1m EUR.
What is Synlab AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-11%
Over the last year, the Cash from Operating Activities growth was -42%. The average annual Cash from Operating Activities growth rates for Synlab AG have been -11% over the past three years .